Clinical laboratory最新文献

筛选
英文 中文
Cytokines and Other Laboratory Parameters of Hospitalized COVID-19 Patients that Predict Intensive Care Unit Admission. 可预测入住重症监护室的 COVID-19 住院患者的细胞因子和其他实验室参数。
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240109
Necati Cakir, Eren Gozke, Semiha C Ekinci, Sinem A Isik, Sibel Osken, Zeynep Kaya, Eylem A Guner, Feyza Ak, Hanife A Yazicilar, Haluk Kilic, Burcu S Anil, Muhammet Ozgul
{"title":"Cytokines and Other Laboratory Parameters of Hospitalized COVID-19 Patients that Predict Intensive Care Unit Admission.","authors":"Necati Cakir, Eren Gozke, Semiha C Ekinci, Sinem A Isik, Sibel Osken, Zeynep Kaya, Eylem A Guner, Feyza Ak, Hanife A Yazicilar, Haluk Kilic, Burcu S Anil, Muhammet Ozgul","doi":"10.7754/Clin.Lab.2024.240109","DOIUrl":"10.7754/Clin.Lab.2024.240109","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the roles of cytokines and other laboratory parameters in determining the need for intensive care in COVID-19 patients.</p><p><strong>Methods: </strong>This is a retrospective observational study. Demographic, clinical, and laboratory parameters of the patients were evaluated. Thirteen cytokines were measured along with baseline laboratory tests at admission and at 48-hour intervals: IL-1β, IFN-α, IFN-β, TNF-α, MCP-1, IL-6, IL -8, IL-10, IL-2p70, IL-17A, IL-18, IL-23, and IL-33.</p><p><strong>Results: </strong>COVID-19 was confirmed by PCR in 116 hospitalized patients. The mean age was 55.3 ± 16.4 years. Seventy-four (63.8%) of the patients were male and 42 (36.2%) were female. Twenty-two (18.9%) patients (16 male, 6 female) were transferred to the intensive care unit. A significant increase in white blood cell (WBC), neutrophil (Neu) and lymphocyte (Lym) counts, Neu/Lym ratio (NLR), lactate dehydrogenase (LDH), INR (international normalized ratio), activated prothrombin time (aPTT), D-dimer (D-D), troponin (Trop), Pro-BNP (BNP), procalcitonin (PCT), ferritin (Fer), and alanine aminotransferase (ALT) values were observed in those requiring intensive care. A significant decrease was found in albumin (Alb) levels and Lym counts. Alb levels appeared to be protective against admission to intensive care. Except for IFN- α, IL-23, and IL-33, the baseline values of other cytokines were above the threshold values. MCP-1 and IL-6 were higher in patients requiring intensive care.</p><p><strong>Conclusions: </strong>High NLR and LDH and low Alb levels, especially with an increase in MCP-1 and IL-6, were found to be the best predictors of a serious COVID-19 infection.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic Exposure and Risk of New-Onset Ulcerative Colitis: a Systematic Review and Meta-Analysis. 抗生素暴露与新发溃疡性结肠炎的风险:系统回顾与元分析。
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240312
Jian-Kang Zhu, Ayinuer Wubulikasimu, Gulipiye Ainiwaer, Aikepaer Aiken, Hasiyeti Aili, Ji-Lin Wang
{"title":"Antibiotic Exposure and Risk of New-Onset Ulcerative Colitis: a Systematic Review and Meta-Analysis.","authors":"Jian-Kang Zhu, Ayinuer Wubulikasimu, Gulipiye Ainiwaer, Aikepaer Aiken, Hasiyeti Aili, Ji-Lin Wang","doi":"10.7754/Clin.Lab.2024.240312","DOIUrl":"10.7754/Clin.Lab.2024.240312","url":null,"abstract":"<p><strong>Background: </strong>Antibiotic exposure has been reported as a risk factor for the development of ulcerative colitis; however, the clinical results were controversial. Therefore, we performed a meta-analysis to evaluate the association of antibiotic exposure with the new onset of UC.</p><p><strong>Methods: </strong>A comprehensive literature search for relevant studies published up to February 2024, exploring the association between antibiotic exposure and new-onset UC, was performed by using Medline and Embase, and the statistical analysis was conducted by using the Stata software.</p><p><strong>Results: </strong>A total of 16 articles were included in the study, including 12 case-control studies and 4 cohort studies. The pooled analysis revealed that antibiotic exposure was associated with an increased risk of new-onset UC (summary OR = 1.28, 95% CI = 1.26 - 1.31). Subgroup analyses showed that both case-control studies and cohort studies have yielded consistent conclusions.</p><p><strong>Conclusions: </strong>This meta-analysis suggests that antibiotic exposure is a risk factor for the development of UC. It is, therefore, necessary to avoid unnecessary and excessive use of antibiotics.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifungal Susceptibility Testing and Cluster Analysis of Candida auris Strains. 白色念珠菌菌株的抗真菌药敏试验和聚类分析
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240317
Gulsah E Ozmerdiven, Arzu Irvem, Zeynep Cizmeci
{"title":"Antifungal Susceptibility Testing and Cluster Analysis of Candida auris Strains.","authors":"Gulsah E Ozmerdiven, Arzu Irvem, Zeynep Cizmeci","doi":"10.7754/Clin.Lab.2024.240317","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240317","url":null,"abstract":"<p><strong>Background: </strong>Candida auris is an opportunistic pathogen that has become widespread in recent years and shows resistance to multiple drugs. The aim of our study was to determine the antifungal susceptibilities of C. auris isolates, to perform a dendrogram from the mass spectra of strains obtained from matrix-assisted laser desorption ionization-time of flight mass spectrometry in order to evaluate the proteomic similarities of the strains and determine the geographical clade of C. auris strains in this study by the help of Multiplex RT-PCR.</p><p><strong>Methods: </strong>The samples yielded 58 C. auris isolates. MALDI TOF MS (BioMerieux, France) was used for identification of the isolates and Sensititre Yeast One (Thermoscientific) system was used for antifungal susceptibility testing. Dendrograms of strain's spectra were generated by using the RUO/Saramis (BioMerieux, France) database and evaluated through hierarchical clustering analysis. The selected nine strains were examined at the clade level by using Multiplex RT-PCR. Results The susceptibility profile of the strains revealed resistance to Fluconazole in 84% (MICs ≥ 32) and resistance to Amphotericin B in 60% (MIC ≥ 2). All strains were found to be sensitive to Anidulafungin and Micafungin. The dendrogram of the main spectra of C. auris isolates showed a similarity range of 35 - 100%. The nine strains studied were identified as clade 1 (South Asian).</p><p><strong>Conclusions: </strong>It was determined that C. auris strains were members of geographical clade 1, and the Amphotericin B resistance was found to be higher than expected. This situation poses a threat to critically ill patients.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-Tuberculous Mycobacterial Pulmonary Disease with Detection of Mycobacterium Tuberculosis in Pleural Fluid. 胸腔积液中检测出结核分枝杆菌的非结核分枝杆菌肺病
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240531
Ling Zhang, Si Y Sun, Xue X Yao, Ai S Fu, Yan L Ge
{"title":"Non-Tuberculous Mycobacterial Pulmonary Disease with Detection of Mycobacterium Tuberculosis in Pleural Fluid.","authors":"Ling Zhang, Si Y Sun, Xue X Yao, Ai S Fu, Yan L Ge","doi":"10.7754/Clin.Lab.2024.240531","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240531","url":null,"abstract":"<p><strong>Background: </strong>Tuberculous pleurisy (TP) is one of the most common types of extrapulmonary tuberculosis, often secondary to tuberculosis (TB). Clinical and imaging manifestations of non-tuberculous mycobacterial pulmonary diseases (NTM-PD) are usually similar to those of tuberculosis. Because of their similarity and the high incidence of tuberculosis, non-tuberculous mycobacterial infections are often overlooked for a long time. Especially in people without immunodeficiency.</p><p><strong>Methods: </strong>Mycobacterium tuberculosis (MTB) in pleural effusion was found by metagenomic next-generation sequencing (mNGS). During anti-tuberculosis treatment, mNGS of lung tissue by ultrasound-guided percutaneous lung puncture revealed that this patient had combined NTM-PD.</p><p><strong>Results: </strong>Mycobacterium chelonae (M. chelonae) was detected by mNGS, and after anti-NTM treatment, the patient's chest CT showed that the inflammation was absorbed more than before, and the patient's symptoms improved.</p><p><strong>Conclusions: </strong>When TB is poorly treated with standardized anti-tuberculosis therapy, comorbid non-tuberculous mycobacterial infections may be considered, and mNGS may complement traditional pathogenetic testing.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Should we Continue to Monitor or Choose to Ignore the Mild Increase in CA19-9 after Surgery. 我们应该继续监测还是选择忽略手术后 CA19-9 的轻度升高?
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240420
Liu Yang, Li Jinchang, Gu Wanjian
{"title":"Should we Continue to Monitor or Choose to Ignore the Mild Increase in CA19-9 after Surgery.","authors":"Liu Yang, Li Jinchang, Gu Wanjian","doi":"10.7754/Clin.Lab.2024.240420","DOIUrl":"10.7754/Clin.Lab.2024.240420","url":null,"abstract":"<p><strong>Background: </strong>Different detection platforms can lead to significant differences in the results of CA19-9. Here, a case of a 38-year-old male colon cancer patient who underwent CA19-9 testing on two platforms after surgery.</p><p><strong>Methods: </strong>We first inspect the instrument to confirm its normal operation and good indoor quality control. Then, we conduct dilution experiments to eliminate interference from heterophilic antibodies, compare and analyze inherent differences with other platforms, and regularly follow up to dynamically monitor the patient's condition.</p><p><strong>Results: </strong>During follow-up, the patient's CA19-9 levels rose consistently on both platforms, leading to tumor recurrence two years later, missing optimal treatment.</p><p><strong>Conclusions: </strong>Dynamic monitoring of tumor markers should be based on a stable platform and combined with imaging examinations. For abnormal elevated results, humanistic care is needed to address the patient's fear and doubts about the test results.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer. 循环肿瘤细胞和 T 淋巴细胞亚群在预测肺癌预后中的临床价值
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.230514
Xi Liu, Xiaosong Yan, Junyu Li, Weimin Mao, Feng Jiang
{"title":"The Clinical Values of Circulating Tumor Cells and T Lymphocyte Subsets in Predicting a Prognosis of Lung Cancer.","authors":"Xi Liu, Xiaosong Yan, Junyu Li, Weimin Mao, Feng Jiang","doi":"10.7754/Clin.Lab.2024.230514","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.230514","url":null,"abstract":"<p><strong>Background: </strong>Lung cancer is the most lethal cancer in men and women. Recently, it has been reported that circu-lating tumor cells (CTCs) are sensitive and reliable biomarkers for tracing relapse and metastasis of cancer patients. Many studies also showed that immune cellular dysfunctions in lung cancer patients are major reasons for cancer development. In this study, we explored the clinical significance of CTCs and T lymphocyte subtypes in lung cancer patients.</p><p><strong>Methods: </strong>A total of 92 patients with diagnosed lung cancer, including 23 squamous-cell carcinoma and 69 adenocarcinoma, were enrolled in this study. Another 10 patients with non-carcinoma nodules in their lungs were also recruited as a control group. Peripheral blood samples were drawn from the patients with lung cancer and from the control cases before the treatment. The identification of CTCs was carried out by a PatrolCTC detection method. The T lymphocyte subtypes were characterized by flow cytometry (FACS). Cytokines interleukin-2 (IL-2), interleukin-4 (IL-4), interleukin-17A (IL-17A), interleukin-10 (IL-10), and interferon  (IFN-) were detected by meso scale discovery (MSD) assay.</p><p><strong>Results: </strong>Out of the enrolled patients, 69 (75%) patients with non-small cell lung cancer (NSCLC) were male and 23 (25 %) were female. Smoking and non-smoking history was 50% (46 cases) each. The case numbers for I - IV tumor-node-metastasis (TNM) stages were 23 (25.0%), 28 (30.4%), 16 (17.4%), and 25 (27.2%), respectively. The positive rates of the CTCs before treatment were 8.7% (2/23), 17.6% (5/28), 81.3% (13/16), and 100% (25/25) in stage I, II, III, and IV patients, respectively. Total CTCs, mixed CTCs, and mesenchymal CTCs (MCTCs) were strongly related to the progression-free survival (PFS) of the patients. In addition, total CTCs (≥ 6) and positive MCTCs also significantly correlated with recurrence and metastasis. The patients with high CTCs also had low levels of CD4, CD4/CD8 ratio, IL-2, and IFN. In contrast, IL-10 in high CTCs patients was significant elevated. These results indicate that the CTC numbers in lung cancer patients are an independent indicator for a worse PFS.</p><p><strong>Conclusions: </strong>Higher total CTCs, mixed CTCs, and MCTCs in peripheral blood were significant biomarkers for predicting the prognosis of lung cancer patients. High CTCs also had a strong correlation with weak cellular immunity functions.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Diagnosis of Nonaccelerating MDS/MPN-U Patient with 5q- Karyotype. 核型为 5q- 的非加速性 MDS/MPN-U 患者的临床特征和诊断。
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240506
Ling Xu, Ruimin Li, Pengcheng Yang
{"title":"Clinical Characteristics and Diagnosis of Nonaccelerating MDS/MPN-U Patient with 5q- Karyotype.","authors":"Ling Xu, Ruimin Li, Pengcheng Yang","doi":"10.7754/Clin.Lab.2024.240506","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240506","url":null,"abstract":"<p><strong>Background: </strong>The aim of the study was to improve the clinical cognition of nonaccelerating myelodysplastic/myeloproliferative neoplasms-unclassifiable (MDS/MPN-U) with 5q- karyotype and to avoid misdiagnosis or delayed diagnosis.</p><p><strong>Methods: </strong>The clinical manifestations and laboratory results of a patient with nonaccelerating MDS/MPN-U with 5q- karyotype were analyzed, and related literature was reviewed.</p><p><strong>Results: </strong>The patient was admitted to hospital mainly due to chest tightness and shortness of breath, aggravated for 4 days. After admission, combined with clinical manifestations, bone marrow cell morphology, immunology, multiparameter flow cytometry, cytogenetics and molecular biology, etc., the final diagnosis was MDS-MPN-U.</p><p><strong>Conclusions: </strong>Research on the correlation between MPN-U and MDS with 5q deletion is still needed. Clinically, MPN-U combined with MDS is prone to misdiagnosis. In diagnosing MPN-U patients, it is essential to not only complete routine and immunological tests but also consider clinical manifestations and laboratory results. It is crucial to be vigilant about the possibility of concurrent diseases, especially cancer, and to choose targeted examinations in a timely manner to avoid missed or incorrect diagnoses.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hematological Parameters of Patients Positive for Coronavirus With and Without Comorbidities. 冠状病毒阳性患者的血液学参数(有无合并症
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240346
Edhem Hasković, Ehlimana Pobrić, Zarema Obradović, Kenan Galijašević
{"title":"Hematological Parameters of Patients Positive for Coronavirus With and Without Comorbidities.","authors":"Edhem Hasković, Ehlimana Pobrić, Zarema Obradović, Kenan Galijašević","doi":"10.7754/Clin.Lab.2024.240346","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240346","url":null,"abstract":"<p><strong>Background: </strong>The causative agent of the coronavirus disease (COVID-19) is a virus from the SARS-CoV-2 group of viruses that cause severe acute respiratory syndrome. The aim of the study was to examine the differences in hematological analyses of patients suffering from COVID-19 with and without comorbidities, to determine the degree of the clinical picture based on the MEWS scale and to examine the persistence of inflammatory parameters with the severity of the clinical picture.</p><p><strong>Methods: </strong>The research is a cross-sectional retrospective study, conducted in the laboratory diagnostics service of Tesanj General Hospital. It included 211 respondents positive for the coronavirus in the Tesanj General Hospital. The degree of severity of the clinical picture was determined on the basis of the MEWS scale.</p><p><strong>Results: </strong>A total of 211 patients positive for coronavirus participated in the study, of which 61.1% (129) were male and 38.9% (82) were female. Based on the results, a statistically significant difference was found in the ratio of hematological parameters in subjects with and without comorbidities (p < 0.05). A strong positive correlation was found between the ratio of SE and D-dimer in subjects and the degree of severity of the clinical picture.</p><p><strong>Conclusions: </strong>A statistically significant difference was recorded in the ratio of hematological parameters (lymphocytes, granulocytes, erythrocytes, hematocrit, and APTT) in subjects with and without comorbidities in all three of the observed groups (p < 0.05), while there were no statistically significant differences in other hematological parameters (p > 0.05).</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Do Parenteral Iron Therapies Preserve or Deteriorate Kidney Functions? "Iron Carboxy Maltose or Iron Sucrose?" 肠外铁疗法会保护还是恶化肾功能?"蔗糖羧麦芽糖铁剂还是蔗糖铁剂?
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240341
Turker Emre, Yalcin Gokmen
{"title":"Do Parenteral Iron Therapies Preserve or Deteriorate Kidney Functions? \"Iron Carboxy Maltose or Iron Sucrose?\"","authors":"Turker Emre, Yalcin Gokmen","doi":"10.7754/Clin.Lab.2024.240341","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240341","url":null,"abstract":"<p><strong>Background: </strong>Treatment of end stage renal disease (ESRD) is based on preserving renal functions. Since renal anemia is frequently detected, we use parenteral iron treatments in patients with chronic kidney disease (CKD). However, there need to be more precise and sufficient studies on the effect of these treatments on the rate of decrease in the glomerular filtration rate (GFR). Therefore, we conducted a study comparing the rates of change in renal function in patients who had used parenteral iron for at least five years.</p><p><strong>Methods: </strong>Our study is a retrospective cohort study, and 180 patients with CKD (86 women, 94 men, mean age: 63.5 ± 11.4 years) who had been followed and treated in nephrology outpatient clinics for at least five years and met the study criteria were included in the study. Patients were divided into three groups for iron therapy: not receiving iron therapy, iron carboxy maltose (ICM), and iron sucrose (IS) parenterally. Each group consisted of 60 people. The first and last creatinine and GFR values were compared for a 5-year follow-up in each group.</p><p><strong>Results: </strong>There was no significant difference between the two groups, those using and those not using iron, regarding creatinine increase and GFR decrease rate. Additionally, no significant difference was detected in the GFR decline rates of patients using ICM and IS.</p><p><strong>Conclusions: </strong>This study reduces the concerns that correcting anemia through parenteral iron therapy in patients with CKD may harm renal function.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case of Neonate Hypoglycemia. 一例新生儿低血糖症。
IF 0.7 4区 医学
Clinical laboratory Pub Date : 2024-10-01 DOI: 10.7754/Clin.Lab.2024.240525
Tao Lu, Gangfeng Li
{"title":"A Case of Neonate Hypoglycemia.","authors":"Tao Lu, Gangfeng Li","doi":"10.7754/Clin.Lab.2024.240525","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2024.240525","url":null,"abstract":"<p><strong>Background: </strong>There has been no unified definition for neonatal hypoglycemia. Generally, neonatal hypoglycemia is diagnosed when the whole blood glucose concentration is below 2.2 mmol/L. The reasons are numerous. This case report presents an instance of a newborn with extremely low blood glucose levels immediately after birth from a diabetic mother, referred to as the \"Infants of Diabetic Mothers\", providing a practical case reference for early monitoring and timely intervention for Infants of Diabetic Mothers (IDMs).</p><p><strong>Methods: </strong>The glucose concentrations in whole blood and serum were measured using a fingerstick glucometer and a fully automatic biochemical analyzer, respectively. The levels of insulin and C-peptide were detected using a fully automatic chemiluminescence method. The glycated hemoglobin was measured using a glycated hemoglobin analyzer.</p><p><strong>Results: </strong>The mother's blood glucose value before delivery was 8.28 mmol/L. After delivery, the fingerstick blood glucose and serum glucose concentrations of the newborn were 2.6 mmol/L and 0.11 mmol/L, respectively. The levels of insulin and C-peptide were 805.55 pmol/L and 2,312.64 pmol/L, respectively. The value of glycated hemoglobin was 7.5%. Intravenous nutrition with a 100 mL of 10% glucose at an infusion rate of 12.7 mL/d was maintained. Then, 10% glucose was given to the neonate at an infusion rate of 7.7 mL/minute for 30 minutes. Eventually, the blood glucose levels were raised to 5.2 mmol/L.</p><p><strong>Conclusions: </strong>Diabetes has a profound impact on both the mother and the newborn. Close monitoring and timely intervention are necessary to reduce neonatal complications and promote longterm healthy growth and development.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"70 10","pages":""},"PeriodicalIF":0.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142388549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信